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Abstract  
The aim of this study was to simulate the effects of tuberculosis (TB) treatment strategies 
interventions in an overcrowded and poorly ventilated prison with both high (5 months) and low (3 
years) turnover of inmates against improved environmental conditions. We used a deterministic 
transmission model to simulate the effects of treatment of latent TB infection and active TB, or the 
combination of both treatment strategies. Without any intervention, the TB prevalence is estimated 
to increase to 8.8% for a prison with low turnover of inmates but modestly stabilize at 5.8% for high-
turnover prisons in a 10-year period. Reducing overcrowding from 6 to 4 inmates per housing cell 
and increasing the ventilation rate from 2 to 12 air changes per hour combined with any treatment 
strategy would further reduce the TB prevalence to as low as 0.98% for a prison with low inmate 
turnover.  
 





Tuberculosis (TB) has overtaken HIV infection as the number one global killer from infectious 
diseases, with an overall 1.7 million TB-related deaths reported in 2016, despite accessibility of TB 
treatment.1 In 2016, the World Health Organization (WHO) estimated a total of 10.4 million incident 
TB cases globally, 10% of whom were living with HIV infection. The burden of TB is highest in the 
South-East Asian and African regions, which accounted for 70% of the global TB incidence in 2016.1  
In Malaysia, TB is the second most frequently reported communicable disease (after dengue fever) 
and is the leading cause of death from communicable disease, with a mortality rate of 5.56 per 100 
000 persons.2 In 2013, the prevalence of active TB was estimated at between 0.06% and 0.23% of 
the general population.3 In recent years, Malaysia has witnessed an increase in the incidence of TB, 
from 65 cases per 100 000 in 2000 to 92 per 100 000 in 2016.1  
Closed settings, including prisons, present special challenges to national TB control programs. 
Prisons are concentrated populations of individuals at high risk of TB, such as people who use drugs 
and/or alcohol, the homeless, people with a history of past incarceration, and people with 
preexisting comorbidities. Poor environmental conditions, such as overcrowding and inadequate 
ventilation, and restricted access to health care services can facilitate the transmission of TB in 
prisons.4,5 The prevalence of TB is estimated to be up to 100 times higher in prisons than in the 
general population.6 Recent reports from 2 Malaysian prisons have shown a very high (>80%) 
prevalence of latent TB infection among prisoners, irrespective of HIV status.7,8 A follow-up 
intensified case-finding survey in one of these prisons reported a high prevalence (7.7%) of 
previously undiagnosed active TB.9 This prison is overcrowded and has a daily census of 4200 
prisoners, operating at 120% of its maximum capacity of 3500.8  
The high burden of TB within prison poses a threat to the general population, as the disease can be 
transmitted to correctional staff who are in daily close contact with prisoners. Furthermore, inmates 
who are incarcerated for a short period of time and who do not receive adequate treatment may 
transmit the disease on their return to the community.10 In a recent systematic review, a large 
fraction of TB cases in the general population was attributable to acquisition of TB inside prison. This 
has been estimated at 1 in 11 TB cases in high-income countries and 1 in 16 cases in low-/middle-
income countries.4 Another study estimated that for each 1% increase in the incarceration rate in 
European and Central Asian countries, there was a 0.34% increase in TB incidence in the general 
population.11  
Despite recent findings of high prevalence rates of both latent and active TB in Malaysian prisons, 
routine intensified TB screening and treatment is not currently practiced, and diagnosis of active TB 
remains passive. Environmental conditions, such as overcrowding and poor ventilation, further 
facilitate the transmission and spread of TB in these settings. The objective of this modelling study is 
to evaluate the impact of implementing TB treatment strategies and of improving environmental 
conditions in the largest Malaysian prison, considering both high (ie, average sentence length of 5 




We constructed a deterministic population-based compartmental model of TB transmission based 
on previously published models.12,13 We simulated infection and reinfection, treatment of 
infectious individuals and latently infected individuals, death due to TB, natural recovery, and 
relapse (Figure 1). Our model divides the inmate population in into 5 compartments reflecting their 
TB status: susceptible (S), short-term latently infected (L1), long-term latently infected (L2), 
infectious (I), and recovered (R). Susceptible inmates acquired TB infection following contact with an 
actively infectious inmate at the rate βI, where β is the transmission rate that one susceptible inmate 
becomes infected following contact with an infectious inmate. On exposure to infectious inmates, 
susceptible inmates who became infected move to the short-term, latently infected compartment 
(L1). A proportion ( ρ : 5% to 10%) of latently infected individuals quickly progress at a rate of σ1 
(within the first 2 years) to the infectious stage, while the majority ( ) 1− ρ progress to the long-term 
latent stage at a slower rate of σ2 (within 5 years).14 Latently infected individuals progressed to the 
active TB compartment at a reactivation rate of ω. Once in the active stage of the disease, inmates 
recovered naturally at a rate of αn or with treatment at a rate of α and moved into the recovered 
compartment. Infectious inmates (I) died from TB at a rate of µ1 and recovered individuals relapsed 
at a rate of r. Environmental factors in prison can increase the risk of infection. Hence, inmates 
become reinfected and return to the L1 compartment at a rate of ( ) 1− f I β . The reinfection 
mechanism occurs in 2 ways: (1) reinfection of recovered-stage inmates and (2) reinfection of long-
term latent-stage inmates. The parameter f represents reduced risk of infection due to acquired 
immunity from a previous infection.14-16 The parameters τ1 and τ2 represent preventive therapy 
initiated during the latent stage. Inmates in our model enter and exit each state at a constant rate, 
Ω. Exiting arrows, which are represented as µ, are not depicted in Figure 1. Details on the model 
equations and sources of data are in the Online Supplementary File (available in the online version of 
the article). Several model parameters (namely, transmission rate, prison entry/exit rate, recovery 
rates, and inmate turnover) could be determined based on Kajang Prison data. Further details of the 
quantification and justification of the transmission rate using the Wells-Riley equation for the 
modelling of airborne transmission and all sources of data used can be found in the Online 
Supplementary File. The initial conditions of the Susceptible and Recovered compartments were set 
based on observed prevalences in Kajang Prison, at 3% and 4%, respectively. In summary, the 
parameters transmission rate, β; rate of exit and entering prison, Ω; and the recovery rates, τ1, τ2 , 
and α, are specific to the Malaysian setting; the remaining parameters were based on data from 
other countries. Further details can be found in the Online Supplementary File.  
Simulation of TB Intervention Strategies 
The first simulation adopted parameters reflecting the current environmental conditions of Kajang 
Prison (ie, overcrowded cell occupancy and poor ventilation; Table 1), with no interventions 
included. We termed this Baseline-A. Then, we ran 3 sets of simulations including the following TB 
interventions: isoniazid preventive therapy (IPT) provided to all latently infected inmates only 
(Strategy 1A); anti-TB treatment (ATBT) provided to all infectious inmates only (Strategy 2A); and 
both ATBT and IPT provided to all infectious and latently infected inmates (Strategy 3A). We 
repeated these simulations by changing the overcrowding factor (reducing the occupancy of the cell 
from 6 inmates [3.33 m2 of floor area per inmate] to 4 inmates per cell [5.40 m2 of floor area per 
inmate]) and improving the ventilation by increasing the air changes from 2 air changes per hour 
(ACH) to 12 ACH (the source of these data can be found in the Online Supplementary File). These 
improved conditions are referred to with the suffix “-B” in Table 1. We also repeated these 
simulations in a scenario where the average sentence is 3 years (vs 5 months) and refer to this 
scenario with the suffix “-3” in Table 1. Uncertainty and sensitivity analyses are elaborated in the 
Online Supplementary File. 
 
Results  
Simulation of TB Intervention Strategies  
Table 2 shows the impact of various strategies on the prevalence of active TB over a period of 10 
years. Figures illustrating the various simulation strategies are available in the Online Supplementary 
File (Figures 1-4).  
With Current Environmental Conditions. Based on the current environmental conditions, if neither 
IPT nor ATBT is implemented (Strategy Baseline-A), the prevalence of active TB will reach a steady 
state of 5.77% (95% confidence interval [CI] = 4.61-6.94) after 2 years, which is lower than the initial 
prevalence of 8% (Figure 1 in the Online Supplementary File). Implementing IPT (Strategy 1A) or 
ATBT (Strategy 2A) would reduce the prevalence to 5.58% (95% CI = 4.60-6.72) and 3.28% (95% CI = 
2.66-3.93), respectively. The combined IPT + ATBT strategy would reduce the prevalence further to 
3.14% (95% CI = 2.66-3.73). In a prison with a longer average sentence (ie, lower turnover rate), 
without any intervention, the prevalence of active TB was estimated to be 8.80% (95% CI = 3.55-
15.04; Strategy Baseline-A3; Figure 2 in the Online Supplementary File); implementation of IPT 
alone, ATBT alone, or IPT + ATBT in this setting would reduce the prevalence of active TB to 7.99% 
(Strategy 1A-3), 1.94% (Strategy 2A-3), and 1.47% (Strategy 3A-3), respectively (Table 2). The 
combined intervention resulted in the lowest prevalence of active TB in both the short (5 months) 
and long (3 years) average sentence length scenarios. 
Impact of Improved Environmental Conditions. In a prison setting with a high turnover of inmates 
(average sentence of 5 months), improving the air ventilation rate from 2 ACH to 12 ACH and 
reducing the occupancy rate from 6 to 4 inmates per cell resulted in a slight reduction of active TB 
prevalence in all simulations, with and without treatment strategies. In the absence of treatment 
(Improved-B), the prevalence of active TB decreased to 5.43% (95% CI = 4.60-6.38; Figure 3 in the 
Online Supplementary File). Introducing IPT (Strategy 1B) or ATBT (Strategy 2B) reduced the 
prevalence to 5.08% (95% CI = 4.55-5.66) and 3.11% (95% CI = 3.27-3.59), respectively. The 
combined strategy (Strategy 3B) resulted in the lowest active TB prevalence (2.92% (95% CI = 2.65-
3.20). Improved environmental conditions resulted in only a minor reduction to the already low 
prevalence of active TB when the combined strategy was implemented (Table 2). However, in a 
prison setting with a low turnover of inmates (3 years), improved environmental conditions further 
reduced the prevalence of active TB to 4.15% (95% CI = 2.80-6.96) with IPT alone (Strategy 1B-3) and 
1.36% (95% CI = 0.73-2.16) with ATBT alone (Strategy 2B-3). The combined strategy (Strategy 3B-3) 
resulted in a prevalence of active TB of 0.98% (95% CI = 0.83-1.17; Figure 4 in the Online 
Supplementary File).  
 
Discussion  
This study simulated the impact of various TB treatment and prevention strategies and modifications 
to environmental factors in a prison setting with a high prevalence of active and latent TB. It also 
explored the impact of inmate turnover rate on prevalence rate under the different intervention 
strategies. Our model suggests that, regardless of inmate turnover rate, the greatest impact on the 
prevalence of active TB can be achieved through provision of ATBT to infectious inmates in 
combination with IPT for latently infected inmates, together with a reduction of overcrowding and 
an improvement in air ventilation rates (Strategies 3A, 3A-3, 3B, and 3B-3). Our model also suggests 
that providing ATBT treatment for those infected with active TB (Strategies 2A, 2A-3, 2B, and 2B-3) 
alone and in combination with IPT, even in the absence of environmental improvements, would 
significantly reduce the prevalence of active TB over a 10-year period. Implementing IPT alone would 
also decrease the prevalence of active TB, but to a lesser extent as compared with ATBT alone or the 
combined treatment strategies.  
Mathematical models of TB in a high prevalence setting have been used to evaluate the impact of 
treating active TB,17 using preventive therapy18,19 and of both interventions.13,20,21 However, 
many of these studies were conducted in open community settings. Modelling studies addressing TB 
in closed settings are very limited. Legrand et al,22 modelled the impact of administrative 
interventions on TB control in closed settings, but did not consider the impact of IPT or 
environmental interventions. Johnstone-Robertson et al,23 and Urrego et al,24 investigated the 
impact of overcrowding and poor ventilation on TB transmission in their modelling, but their 
analyses were limited to new infections and did not consider disease progression.  
In our model, in the absence of treatment strategies, a prison with longer average sentences of 3 
years (representing a low inmate turnover rate) developed a higher prevalence of active TB 
compared with a prison with a shorter average sentence of 5 months (high turnover rate). This 
finding is consistent with previous studies showing that inmates with longer sentences have a higher 
risk of infection because of greater exposure to infectious inmates.25,26 Reducing inmate 
overcrowding and enhancing quality of ventilation had a smaller impact on reducing TB transmission 
in prisons than treatment strategies. Without any treatment interventions, improvement of 
environmental conditions has little impact because inmates with preexisting comorbidities are still 
highly vulnerable to infection and thus progression to the infectious stage, and so contribute to the 
escalation of TB transmission. A study assessing risk factors of TB in 12 prisons in Brazil found that in 
a high-burden prison, the estimated time from infection to disease onset is around 180 days.25 In 
prisons with longer average sentences and poor environmental conditions, latently infected inmates 
would have sufficient time to progress to the actively infectious stage and consequently escalate TB 
transmission in the prison.25  
 
Interestingly, our findings showed that the impact of treatment interventions is greater for prisons 
with longer average sentences compared with prisons with shorter average sentences. For example, 
when IPT + ATBT (Strategy 3) was implemented, the prevalence of TB was reduced by more than 
half, from 3.14% to 1.47% when the average sentence length was increased from 5 months to 3 
years. Treatment strategies were less effective for prisons with shorter sentences because these 
prisons function as a queuing system: a prison has a maximum capacity—it is only able to hold a 
certain number of inmates at any point—and exiting inmates get replaced by new inmates who are 
at a high risk of being infectious because of the nature of this population.26 Releasing inmates early 
from a prison without implementing any TB interventions for the incoming “potential” inmates could 
therefore contribute to increased TB prevalence in the community over time.  
One of the main factors responsible for a high rate of TB transmission in prison compared with the 
general population is the overcrowding, which affects ventilation.27 Our model suggests that 
improving ventilation and reducing cell occupancy have a notable impact on the prevalence of active 
TB. However, this impact is comparatively greater when a treatment strategy is concurrently 
introduced and when the changes are implemented in a prison with a longer average sentence. This 
finding concurs with a recent study in a highly endemic Brazilian prison that found that improving 
ventilation reduced the TB transmission risk by 38.2%.24 However, this study differed 
methodologically from ours in that it applied a revised Wells-Riley equation in estimating the 
probability of infection in the presence of one infectious individual in a cell. Our study adopted the 
approach of Noakes et al,28 which addressed the limitations of ventilation-based models of indoor 
airborne transmission by combining this approach with a classical SEIR epidemic model. 
Our model has several limitations. We used a dynamic transmission model to project the impact of 
TB control strategies over time; the model assumes homogenous mixing, which is a potentially 
important oversimplification of the actual context. The airborne transmission model used was based 
on the even distribution of infectious particles in a room and does not account for how the 
probability of infection is modified by complexities, such as the distance between individual 
prisoners. Our study was based on data from a single prison and thus may not be representative of 
all prisons in Malaysia. Nevertheless, the overcrowded and poorly ventilated Kajang prison 
represents a common prison setting in many low- and middle-income countries. Our model 
therefore may be applicable to similar prisons in Malaysia with high TB prevalence.  
Although our study looked at TB control measures based on treatment of active and latent 
infections, we did not simulate delays in initiating screening, diagnosing, and treating TB.22 Given 
the low prevalence of drug-resistance reported to date (<1%), we did not consider effects of drug-
resistance and drug-sensitive strains.29 We did not model possible IPT-related adverse events, as a 
systematic review found that isoniazid-induced hepatotoxicity among high-risk groups was rare.30 
Finally, in contrast to numerous prisons around the world, the HIV seroprevalence in Kajang prison is 
moderately low (3%).8 We therefore did not consider the effect of HIV infection on TB. Due to the 
lack of local parameter estimates, the parameters for natural progression of TB disease used to 
inform our model additionally relied on available published studies from other countries, mainly 
modelling studies from developed countries in Western Europe and the United Kingdom. Estimates 
from these studies may differ from those for our local, higher risk population. Previous TB modelling 
studies in prison in Brazil and South Africa faced similar challenges, as they had to rely on studies to 
estimate disease progression rates.20-24,26 Our findings should be viewed as the beginning stage 
for further research, while at the same time highlighting the need for and potential of immediate 
action to address TB transmission in prisons. Without intervention, TB prevalence will remain high 
and contribute to the burden of TB in the prison as well as in the general population. 
 
Conclusions  
Our model demonstrated that implementation of environmental controls combined with treatment 
and prevention strategies can reduce the prevalence of active TB in a crowded prison setting. 
However, the impact is comparatively greater for prisons with a longer average sentence duration 
than with shorter average sentences. Theoretically, provision of treatment should be feasible given 
that these individuals are confined within the prison, reducing the probability of treatment 
nonadherence; in reality, many prisons—particularly in low- and middle-income settings—lack even 
basic medical care for inmates. Our simulation results suggest that ensuring adequate treatment for 
those infected with TB and improvements in the environmental conditions within these closed 
settings can greatly reduce the burden of TB in prison and, ultimately, in the general population. 
 
Authors’ Note  
The data sets used during the current study are available from the corresponding author on 
reasonable request. All data generated or analyzed during this study are included in this article and 
the online supplementary file.  
 
Declaration of Conflicting Interests  
The author(s) declare no potential conflicts of interest with respect to the research, authorship, 
and/or publication of this article.  
 
Funding  
The author(s) disclose receipt of the following financial support for the research, authorship, and/or 
publication of this article: Funding for this project was provided by the University of Malaya 
(University Malaya Research Grant [UMRG] RP004J-13ICT, Demographic Network Modeling of the 
Spread of Infectious Diseases and High Impact Research Grant HIR H-20001-E000092, Mitigation the 
Malaysia HIV Epidemic with a Comprehensive Research Programme). 
 
References  
1. World Health Organization. Global Tuberculosis Report 2017. Geneva, Switzerland: World Health 
Organization; 2017.  
2. Ministry of Health Malaysia. Health Facts 2016. Putrajaya, Malaysia: Ministry of Health Malaysia, 
Planning Division, Health Informatics Centre; 2016.  
3. World Health Organization. Malaysia. Tuberculosis profile 2013. https://extranet.who.int/sree/ 
Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=my&outt 
ype=pdf. Accessed November 20, 2014.  
4. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: 
a systematic review. PLoS Med. 2010;7:e1000381.  
5. Getahun H, Gunneberg C, Sculier D, Verster A, Raviglione M. Tuberculosis and HIV in people who 
inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Curr Opin 
HIV AIDS. 2012;7:345-353.  
6. Bone A, Aerts A, Grzemska M, et al; WHO Global Tuberculosis Programme; International 
Committee of the Red Cross. Tuberculosis Control in Prisons: A Manual for Programme Managers. 
Geneva, Switzerland: World Health Organization; 2000.  
7. Margolis B, Al-Darraji HA, Wickersham JA, Kamarulzaman A, Altice FL. Prevalence of tuberculosis 
symptoms and latent tuberculous infection among prisoners in northeastern Malaysia. Int J Tuberc 
Lung Dis. 2013;17:1538-1544.  
8. Al-Darraji HAA, Kamarulzaman A, Altice FL. Latent tuberculosis infection in a Malaysian prison: 
implications for a comprehensive integrated control program in prisons. BMC Public Health. 
2014;14:22.  
9. Al-Darraji HA, Altice FL, Kamarulzaman A. Undiagnosed pulmonary tuberculosis among prisoners 
in Malaysia: an overlooked risk for tuberculosis in the community. Trop Med Int Health. 2016;21: 
1049-1058.  
10. PLoS Medicine Editors. The health crisis of tuberculosis in prisons extends beyond the prison 
walls. PLoS Med. 2010;7:e1000383.  
11. Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population increases in TB 
and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A. 
2008;105:13280-13285.  
12. Gomes GMM, Rodrigues P, Hilker FM, et al. Implications of partial immunity on the prospects for 
tuberculosis control by post-exposure interventions. J Theor Biol. 2007;248:608-617.  
13. Silva CJ, Torres DFM. Optimal control for a tuberculosis model with reinfection and post-
exposure interventions. Math Biosci. 2013;244:154-164.  
14. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks 
of disease and the role of reinfection. Epidemiol Infect. 1997;119:183-201.  
15. Dowdy DW, Dye C, Cohen T. Data needs for evidence-based decisions: a tuberculosis modeler’s 
“wish list.” Int J Tuberc Lung Dis. 2013;17:866-877.  
16. Sutherland I, Svandova E, Radhakrishna S. The development of clinical tuberculosis following 
infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis 
following infection, linking from data on the risk of tuberculous infection and the incidence of clinical 
tuberculosis in the Netherlands. Tubercle. 1982;63:255-268.  
17. Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under 
the WHO DOTS strategy. Directly observed short-course therapy. Lancet. 1998;352:1886-1891.  
18. Mushayabasa S, Bhunu CP. Modeling the impact of early therapy for latent tuberculosis patients 
and its optimal control analysis. J Biol Phys. 2013;39:723-747.  
19. Ziv E, Daley CL, Blower SM. Early therapy for latent tuberculosis infection. Am J Epidemiol. 
2001;153:381-385. 
20. Basu S, Andrews JR, Poolman EM, et al. Prevention of nosocomial transmission of extensively 
drugresistant tuberculosis in rural South African district hospitals: an epidemiological modelling 
study. Lancet. 2007;370:1500-1507.  
21. Bhunu CP, Garira W, Mukandavire Z, Zimba M. Tuberculosis transmission model with 
chemoprophylaxis and treatment. Bull Math Biol. 2008;70:1163-1191.  
22. Legrand J, Sanchez A, Le Pont F, Camacho L, Larouze B. Modeling the impact of tuberculosis 
control strategies in highly endemic overcrowded prisons. PLoS One. 2008;3:e2100.  
23. Johnstone-Robertson S, Lawn SD, Welte A, Bekker LG, Wood R. Tuberculosis in a South African 
prison—a transmission modelling analysis. S Afr Med J. 2011;101:809-813.  
24. Urrego J, Ko AI, da Silva Santos Carbone A, et al. The impact of ventilation and early diagnosis on 
tuberculosis transmission in Brazilian prisons. Am J Trop Med Hyg. 2015;93:739-746.  
25. Ada CS, Paiao DS, Sgarbi RV, et al. Active and latent tuberculosis in Brazilian correctional 
facilities: a cross-sectional study. BMC Infect Dis. 2015;15:24.  
26. Basu S, Stuckler D, McKee M. Addressing institutional amplifiers in the dynamics and control of 
tuberculosis epidemics. Am J Trop Med Hyg. 2011;84:30-37.  
27. World Health Organization. WHO policy on TB Infection Control in Health-Care Facilities, 
Congregrate Settings and Households. Geneva, Switzerland: World Health Organization; 2009.  
28. Noakes CJ, Beggs CB, Sleigh PA, Kerr KG. Modelling the transmission of airborne infections in 
enclosed spaces. Epidemiol Infect. 2006;134:1082-1091.  
29. Ministry of Health. Clinical Practice Guidelines. Management of Tuberculosis. 3rd ed. Kuala 
Lumpur, Malaysia: Ministry of Health; 2012.  
30. Bliven EE, Podewils LJ. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment 
for latent tuberculosis infection. Int J Tuberc Lung Dis. 2009;13:1054-1060. 
